Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: Celgene CVR From BMS Buyout Falls Through

Jan 04 2021

• By Joseph Haas, Anju Ghangurde, and Jung Won Shin

DealWatch_1200x675

Related Content

Setback For Glenmark As FDA Hands Out CRL For Ryaltris

Jun 26 2019

Richter And Mithra Extend Estelle To Latin America

Dec 23 2020

Glenmark Partners With Menarini On Ryaltris

Jan 04 2021

Menarini Expands In Cancer With Radius Drug Deal

Jul 27 2020

M&A Already Underway As Angelini Acquires Arvelle

Jan 04 2021

Biomm Backs Bio-Thera’s Brazilian Bevacizumab

Dec 21 2020

Deal Watch: Roche Partners With Dyno On AAV-Delivered Gene Therapies

Oct 14 2020

‘Painful’ Few Years In US For Glenmark But Rebound In Sight

Nov 10 2020

It Was Inevitable: FDA Inspection Delay Postpones BMS’s Liso-Cel Approval

Nov 17 2020

Bristol Launches Zeposia For MS, Sees Advantages In The COVID-19 Environment

Jun 01 2020

Amgen's $13.4bn Otezla Buy Helps Bristol/Celgene Merger Close By Year-End

Aug 27 2019

2021 Deal Action In India: Watch Private Equity And E-Pharmacy

Jan 04 2021

Indian Companies Find US Partners For COVID-19 Vaccines

Dec 24 2020

Y-mAbs Gives Thanks For First Approved Drug Danyelza

Nov 27 2020

Agios Sells Cancer Portfolio To Servier To Focus On Genetic Diseases

Dec 22 2020

Vertex Inks RNA Splicing Pact With Skyhawk

Dec 22 2020

Pfizer Gains New Commercial Drug Orgovyx In Deal With Myovant

Dec 28 2020

Finance Watch: The Growing $100m-Plus VC Club

Aug 27 2020

Related Companies

Amgen, Inc.

Medicines Development for Global Health

Celgene Corporation

Nxera Pharma Co., Ltd.

Kiora Pharmaceuticals, Inc.

Panoptes Pharma GmbH

Genexine Inc.

Glenmark Pharmaceuticals Limited

Hikma Pharmaceuticals plc

Yuhan Corporation

Grand Pharmaceutical Group Limited

Y-mAbs Therapeutics Inc.

United Therapeutics Corporation

MannKind Corporation

Memorial Sloan Kettering Cancer Center

Clene, Inc.

Elevar Therapeutics, Inc.

Inceptua Group

Vivesto AB

taiba-ME

Additional Topics

Deals Business Strategies M & A Commercial BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.